We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.07 | -0.23% | 29.75 | 29.55 | 30.50 | 30.05 | 29.53 | 29.80 | 5,444,214 | 21:57:01 |
From May 2019 to May 2024
By Sarah Sloat
Swiss pharma giant Roche Holding AG (ROG.EB) on Thursday said its net profit rose in the first half, and raised its sales outlook for the year.
After-tax profit grew in the first half to 8.9 billion Swiss francs ($9.0 billion) from CHF7.5 billion in the same period a year earlier. First-half sales grew to CHF30.5 billion from CHF28.1 billion, helped by growth in both its pharmaceuticals and diagnostics divisions.
"In the first half of the year, we achieved very strong results, driven by high demand for our new medicines," Chief Executive Severin Schwan said.
Roche raised its sales outlook for the full year and said it now expects mid-to-high-single-digit growth at constant exchange rates. Core earnings per share should grow broadly in line with sales, it said.
The company repeated that it expects to increase its Swiss-franc dividend.
Write to Sarah Sloat at sarah.sloat@wsj.com
(END) Dow Jones Newswires
July 25, 2019 01:31 ET (05:31 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
